Brochure
9 Oct 2025

Brief Introduction

PNG 261 kB

Xiangbei Welman, a Chinese leading pharmaceutical company specialized in R&D, manufacturing and sales of API and FDF, is a leading enterprise of fixed-dose antibiotic combination products. Welman has 10 GMP-compliant production lines including penicillin/cephalosporin powder for injection, sterile eye drop & nasal spray, tablets, hard capsules, dry mixed suspension, granules, and oral solid dosage forms. Mian product: Piperacillin Sodium and Tazobactam Sodium(8:1), Tazobactam Sodium, Tadalafil, Ceftazidime and Avibactam Sodium for injection, Amoxicillin and Clavulanate Potassium Tablet

Content provided by our supplier

Xiangbei Welman Pharmaceutical Co. Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2016
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
CMO/CDMO
Consultancy
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Generic APIs producer
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs

Other Content from Xiangbei Welman Pharmaceutical Co. Ltd. ()